Pegylated interferon alfa-2a benzyl alcohol-free formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated interferon alfa-2a benzyl alcohol-free formulation, covering 2017-03-13 to 2017-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Bioequivalence Study of Pegylated Interferon Alfa-2a (PEG-IFN Alfa-2a) Benzyl Alcohol (BA)-Free Formulation Versus PEG-IFN Alfa-2a (Pegasys) Following Subcutaneous Administration [Phase 1]